APA (7th ed.) Citation

Checa, R., Montoya, A., Ortega, N., González-Fraga, J. L., Bartolomé, A., Gálvez, R., . . . Miró, G. (2017). Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm. Parasites & Vectors, 10, 1. https://doi.org/10.1186/s13071-017-2049-0

Chicago Style (17th ed.) Citation

Checa, Rocío, Ana Montoya, Nieves Ortega, José Luis González-Fraga, Adrián Bartolomé, Rosa Gálvez, Valentina Marino, and Guadalupe Miró. "Efficacy, Safety and Tolerance of Imidocarb Dipropionate Versus Atovaquone or Buparvaquone Plus Azithromycin Used to Treat Sick Dogs Naturally Infected with the Babesia Microti-like Piroplasm." Parasites & Vectors 10 (2017): 1. https://doi.org/10.1186/s13071-017-2049-0.

MLA (9th ed.) Citation

Checa, Rocío, et al. "Efficacy, Safety and Tolerance of Imidocarb Dipropionate Versus Atovaquone or Buparvaquone Plus Azithromycin Used to Treat Sick Dogs Naturally Infected with the Babesia Microti-like Piroplasm." Parasites & Vectors, vol. 10, 2017, p. 1, https://doi.org/10.1186/s13071-017-2049-0.